CHKA and breast cancer: Inhibition of CHKα by EB-3D, a selective CHKα inhibitor, induced senescence in breast cancer cell lines through stimulation of the 5′ AMP-activated protein kinase (AMPK)-mTOR pathway and impaired breast cancer cell proliferation, migration, and invasion accompanied by the loss of mesenchymal markers [170].